This bill continues the work of the Energy and Commerce Committee last Congress where we marked up a discussion draft of this very bill at the Health Subcommittee, which I chaired. Drug pricing remains an issue for patients in the United States and this bill will allow the House to act on factual analysis and recommendations to help lower drug prices for Americans. Mr. Speaker, I urge fellow Members to support H.R. 1781, and I reserve the balance of my time.
Share
More from Michael Burgess
This is a national emergency. This is something we have got to address and save Americans, 200 every day.
I will simply underscore the fact that entry- level chemists at the EPA are hired at much higher than the GSA rate. These are not highly sought-after scientists. These are entry-level applicants, and there is no shortage of applicants for…
I am pleased to yield 4 minutes to the gentleman from Missouri (Mr. Alford) for his comments.
I never expected that CMMI was actually going to deliver the cost savings that was promised.
Other voices in this conversation
